What does the published scientific research say about Trichoderma virens?

Trichoderma virens (synonym Gliocladium virens), a deuteromycete soil fungus, is represented by 8 PubMed articles in a plant-input context. The peer-reviewed literature consistently positions it as a biocontrol agent applied against soilborne pathogens — including Pythium ultimum, Rhizoctonia solani, Sclerotinia sclerotiorum, and Fusarium species — through mycoparasitism, antibiosis, and competition in the rhizosphere.

Research on Trichoderma virens gliotoxin production shows this secondary metabolite drives mycoparasitism against P. ultimum and, in tomato studies, primes systemic plant immunity by inducing defense genes including PR1 and Pti-5. The literature also characterizes a 62.8-kb peptaibol synthetase and a Psy1-encoded siderophore pathway (producing dimerum acid) as additional molecular mechanisms underlying its antagonistic activity — findings from gene-disruption experiments, not from regulatory submissions.

Peer-reviewed studies report that Trichoderma virens plant growth promotion is enhanced when co-inoculated with plant growth-promoting bacteria, with Fusarium brachygibbosum inhibition reaching up to 78.6% in certain consortia. The literature also cites T. virens among Trichoderma species studied for nematode suppression — including Meloidogyne and Pratylenchus — through lytic enzymes and phytohormone modulation, though these are reported research findings, not approved label claims or regulatory endorsements.